Pangenomic Health Inc.
Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness… Read more
Pangenomic Health Inc. (LL3) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.827x
Based on the latest financial reports, Pangenomic Health Inc. (LL3) has a cash flow conversion efficiency ratio of 0.827x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.47 Million) by net assets (€-1.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pangenomic Health Inc. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Pangenomic Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pangenomic Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pangenomic Health Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Scandium Canada Ltd
PINK:SCDCF
|
-0.046x |
|
Titanium Sands Ltd
AU:TSL
|
-0.020x |
|
Evolva Holding SA
PINK:ELVAF
|
0.187x |
|
Ni Hsin Resources Bhd
KLSE:7215
|
0.000x |
|
KT Medical Service PCL
BK:KTMS
|
0.030x |
|
MAST ENERGY DEV. LS -001
F:97D
|
N/A |
|
Breakthrough Minerals Ltd
AU:BTM
|
-0.155x |
|
Ulima Nitra PT
JK:UNIQ
|
0.040x |
Annual Cash Flow Conversion Efficiency for Pangenomic Health Inc. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Pangenomic Health Inc. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-2.41 Million | €-58.25K | 0.024x | -96.69% |
| 2023-12-31 | €-2.14 Million | €-1.57 Million | 0.731x | -94.35% |
| 2022-12-31 | €-215.11K | €-2.78 Million | 12.935x | +2838.51% |
| 2021-12-31 | €2.24 Million | €-1.06 Million | -0.472x | -- |